Janssen Seeking Ethicists’ Input on Compassionate Use

Drug Industry Daily
A A
Johnson & Johnson’s Janssen subsidiary has enlisted a leading bioethicist to help the company determine who should qualify for compassionate use of its experimental drugs, in what J&J is billing as a first-of-its-kind partnership.

To View This Article:

Login

Subscribe To Drug Industry Daily